The United Kingdom is going big on biotech. As the largest publicly funded healthcare service in the world, the country believes the National Health Service, or NHS, will benefit greatly from innovations in the health sector. As such, it’s creating new incentives to entice private companies in the space. These are some of the top biotech companies to know about as the country continues to invest in its health system.
Top Biotech Companies in the UK to Know
- Endpoint Clinical
- Takeda
- Novo Nordisk
- GlycanAge
- AstraZeneca
- Samphire Neuroscience
Top Biotech Companies in the UK
Novo Nordisk is a biotechnology company developing treatments and solutions for diabetes and other chronic diseases. The company is a leader in discovering and using protein treatments for its therapies, and it has previously developed treatments using gene editing and RNA interface techniques. The company follows a rigorous testing phase for its treatments.
Takeda is a global biotech company developing medical treatments in many fields. The company is known for working with local regulatory agencies to develop products to cure rare diseases and conditions related to neuroscience, oncology and gastroenterology, among other medical areas.
Oxford-based Refeyn develops mass photometry tools to monitor molecules. Its products can weigh individual molecules and unlock analytical insights like structural composition and biomolecule dynamics.
Dr. Reddy’s Laboratories is an Indian pharmaceutical company operating in the U.K. The company manufactures affordable generic medicines in various formulations, from tablets to injectable solutions. Dr. Reddy’s Laboratories also conducts medical research to produce complex molecules for specialized uses.
Insulet is a medical device company that treats people with diabetes. Through its Omnipod platform, individuals can monitor their insulin levels and receive doses through a wearable device that requires no injections. Insulet is headquartered in the United States, with an office in London.
Situated in Granta Park, a top biotech hub in the U.K., Amphista Therapeutics is developing new medical treatment types to fight off diseases. It is currently developing targeted glue treatments, which enable it to target tissue areas larger than traditional therapies and remove pathogenic proteins.
Quell Therapeutics is developing cell therapy solutions to treat solid organ transplants and auto-immune conditions. Launched in 2019, the company uses T cells to develop therapies and use their immune tolerance properties for various medical applications. According to Quell, several of its therapies are in the trial and pre-trial phases.
GlycanAge is a biotechnology company focusing on glycobiology — the science of aging. The company develops medical tests that measure a person’s biological age and provide insight into overall health. With the test, GlycanAge schedules a consultation with a care team that will go over the results and provide recommendations.
AstraZeneca is a pharmaceutical research and biotechnology company headquartered in Cambridge. The company focuses on developing treatments for several therapy areas including cardiovascular and metabolism. AstraZeneca was also one of the first companies to develop a Covid-19 vaccine.
Apollo Therapeutics employs pharmaceutical and subject matter experts who analyze different research programs and provide support to those with strong hypotheses. With its unique research model, Apollo has secured partnerships with leading research universities and pharmaceutical corporations.
Immunocure develops T cell therapies to improve medical outcomes for patients with cancer, infectious diseases and autoimmune disorders. Using research from Oxford, its therapies are designed to activate the immune system and find infected cells to target. Immunocore currently has several treatments in clinical trial stages.
Haleon develops and manufactures several widely popular over-the-counter medical products. Its lineup includes brands like Advil, TUMS and Sensodyne, among others. Haleon is headquartered in the U.K., with an expansive network of facilities worldwide.
Hikma has a significant manufacturing and research presence and develops several hundred generic and specialty pharmaceutical products. One of its most prominent business sectors is developing injectables, which it distributes across North America, Europe, and the Middle East and North Africa, or MENA, region.
Samphire Neuroscience develops wearable devices to manage premenstrual syndrome, or PMS, and menstrual pain. With its wearable device called Nettle, people experiencing menstrual pain may alleviate symptoms by receiving transcranial direct current stimulation to specific regions of the brain. The company also develops solutions for postpartum depression and menopause.
Endpoint Clinical makes interactive response technology products for the life sciences industry. IRT tools and platforms work by managing logistics for the patient-participant and drug supply sides of clinical trials for medications, medical devices and other biotech products. Endpoint’s tech facilitates patient randomization and manages clinical supplies for trials.
Autolus Therapeutics develops Chimeric Antigen Receptors, or CAR, T cell treatments that can help patients with various cancers and autoimmune diseases. By using antigen receptors and T cells, the company can engineer highly accurate therapies to break down cancer cells.
GSK is a global pharmaceutical company that develops treatments for novel diseases. Its products treat illnesses like polio, measles and HIV, among others. GSK has an extensive research and manufacturing presence across multiple countries and a similarly impressive supply chain network to source raw materials and move materials across facilities.
Clock.bio is an up-and-coming biotech startup out of Cambridge. The company is developing anti-aging treatments using induced pluripotent stem cells, or iPSCs. According to the company, its treatments can trigger self-rejuvenation mechanisms found in stem cells.
LabGenius is a London-based biotechnology company that uses AI and machine learning to develop protein therapeutics. Using its evolution engine, the company has an accelerated development approach that enables it to discover antibodies and predict their effectiveness.
Abcam specializes in identifying and developing biological products, such as antibodies, used for research. Additionally, Abcam partners with various institutions to co-develop binders for drug discovery.
Related Articles
Explore Our UK Coverage
Built In London | Built In Manchester | Built In Bristol | Built In Edinburgh | Built In Belfast
